BNF.org

British National Formulary

BNF: ENTER

Preparations launched since BNF 56

(updated 13 November 2008)

Proprietary names link to more details below

Proprietary name Generic name Manufacturer Proposed BNF section
Doribax Doripenem Janssen-Cilag 5.1.2
Relistor Methylnaltrexone Wyeth 1.6
Toctino Alitretinoin Basilea 13.5.1
Volibris Ambrisentan GSK 2.5.1

Doribax® (Janssen-Cilag)black triangleprescription-only medicine

Intravenous infusion, powder for reconstitution, doripenem (as monohydrate), net price 500-mg vial = £15.11

BNF section 5.1.2. For the treatment of hospital-acquired pneumonia (including ventilator-associated pneumonia), complicated intra-abdominal infections, and complicated urinary-tract infections in adults

Relistor® (Wyeth)black triangleprescription-only medicine

Injection, methylnaltrexone 20 mg/mL, net price 0.6 mL vial = £21.05, 7-vial pack = £147.35. For subcutaneous injection

BNF section 1.6. Laxatives. For the treatment of opioid-induced constipation in advanced illness patients who are receiveing palliative care when response to usual laxative therapy is inadequate

Toctino® (Basilea)black triangleprescription-only medicine

Capsules, alitretinoin 10 mg (brown), net price 30-cap pack = £411.43; 30 mg (red-brown), 30-cap pack = £411.43. Label: 10, patient information leaflet, 21

BNF section 13.5.1. For severe, refractory chronic hand eczema

Volibris® (GSK)black triangleprescription-only medicine

Tablets, f/c, ambrisentan 5 mg (pale pink), net price 30-tab pack = £1651.07; 10 mg (dark pink), 30-tab pack = £1651.07

BNF section 2.5.1. For the treatment of pulmonary arterial hypertension under specialist supervision

 

BNF EXTRA

Copyright © BMJ Group and RPS Publishing 2008. All rights reserved.